Recro Pharma announces new IV meloxicam data publication
Recro Pharma announced the publication of new intravenous meloxicam data. The article, titled “Meloxicam intravenous for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects,” was published in Regional Anesthesia & Pain Medicine. February 20, 2019